title: Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B?
authors.forename: Alfredo
authors.initials: A
authors.lastname: Alberti
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000032:analysis; D006515:Hepatitis B virus / Q000235:genetics / Q000302:isolation & purification*; D019694:Hepatitis B, Chronic / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans
chemical_list: D000998:Antiviral Agents; D004279:DNA, Viral